Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Measured vs Mochi Health

Measured
Graded #58

Higher grade

vs+22.799999999999997
Mochi Health
Graded #481

Lower grade

The verdict

Measured takes it — 75.1/100 to 52.3/100.

Measured grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Metabolic-health membership pairing GLP-1 treatment with 1:1 nutrition support and board-certified provider care.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMeasured +41
86
45
Dose & formulationMeasured +37
77
40
Clinical oversightMeasured +16
87
71
Labs & monitoringMeasured +11
63
52
FulfillmentMeasured +2
67
65
Contract termsEven
41
41
Measured · left barMochi Health · right bar

The numbers

MetricMeasuredMochi Health
WeighScore75.1/10052.3/100
GradeCC
Scorecard rank#58#481
Semaglutide$119/mo (compounded)Not disclosed
Tirzepatide$229/mo (compounded)Not disclosed
CoverageCoverage not published15 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Measured

Graded #58 · C

Strengths

  • Membership includes 1:1 nutrition support and board-certified provider care
  • Both compounded (from $79/mo microdose, $119 semaglutide, $229 tirzepatide) and brand-name Wegovy/Zepbound
  • Insurance or cash-pay options for brand-name medications
  • Oral option available (Wegovy pill); cancel-anytime membership

Where it loses points

  • Membership ($49/mo) is billed separately on top of medication cost
  • Compounded medications are not FDA-approved
  • Compounding/dispensing pharmacies not individually named
  • State availability not published
Mochi Health

Graded #481 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard